Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001801170-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-01 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $0.95 | -1,559 | 2.53M | -0.1% | -$1,481 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-01 | F | D | 1,559 | $0.95 | 2,528,380 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 1, 2024, of the last third of the number of restricted stock units (RSUs) granted to the Reporting Person on January 31, 2022, upon the achievement of certain performance criteria underlying a performance-based RSU award that was granted on July 16, 2021. (F2) Amount of securities beneficially owned reflects the amount in the Form 4/A filed on January 3, 2024. |